Investigating the Immunotherapeutic Properties of the DKK1 Antibody, DKN-01, in Pre-Clinical Models of Melanoma
Research Grant
Administered By
Medicine, Medical Oncology
Awarded By
Leap Therapeutics, Inc.
Start Date
November 26, 2018
End Date
May 26, 2022
Administered By
Medicine, Medical Oncology
Awarded By
Leap Therapeutics, Inc.
Start Date
November 26, 2018
End Date
May 26, 2022